{"orpha":664734,"name":"EBV susceptibility with hemophagocytic lymphohistiocytosis as a major feature","type":"Clinical group","group":"Group of disorders","status":"active","flags":[],"synonyms":["Epstein-Barr virus susceptibility with hemophagocytic lymphohistiocytosis as a major feature"],"definition":null,"note":"This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.","url":"https://raremap.alftech.space/d/ORPHA-664734/","orphanet_url":"https://www.orpha.net/en/disease/detail/664734","names":{"fr":{"name":"Susceptibilité à l'EBV avec lymphohistiocytose comme manifestation majeure","synonyms":["Susceptibilité au virus Epstein-Barr avec lymphohistiocytose hémophagocytaire comme manifestation majeure","Susceptibilité à l'EBV avec hémagophagocytose lymphohistiocytaire comme manifestation majeure"]},"de":{"name":"EBV-Suszeptibilität mit hämophagozytischer Lymphohistiozytose als Hauptmerkmal","synonyms":["Epstein-Barr-Virus-Suszeptibilität mit hämophagozytischer Lymphohistiozytose als Hauptmerkmal"]},"es":{"name":"Susceptibilidad al EBV con linfohistiocitosis hemofagocítica como característica principal","synonyms":["Susceptibilidad al virus de Epstein-Barr con linfohistiocitosis hemofagocítica como característica principal"]},"it":{"name":"Suscettibilità al virus di Epstein-Barr con linfoistiocitosi emofagocitica come caratteristica principale","synonyms":["Predisposizione al virus di Epstein-Barr con linfoistiocitosi emofagocitica come caratteristica principale","Suscettibilità al virus di Epstein-Barr con linfoistiocitosi emofagocitica come caratteristica principale"]},"nl":{"name":"EBV-susceptibiliteit met hemofagocytaire lymfohistiocytose als hoofdkenmerk","synonyms":["Susceptibiliteit voor Epstein-Barrvirus met hemofagocytaire lymfohistiocytose als hoofdkenmerk"]},"pt":{"name":"Suscetibilidade a EBV com linfohistiocitose hemofagocítica como característica principal","synonyms":["Suscetibilidade a virus Epstein-Barr com linfohistiocitose hemofagocítica como característica principal"]},"pl":{"name":"Podatność za zakażenie EBV z limfohistiocytozą hemofagocytarną jako główną cechą","synonyms":["Epstein-Barr virus susceptibility with hemophagocytic lymphohistiocytosis as a major feature"]},"cs":{"name":"Vnímavost k EBV s hemofagocytární lymfohistiocytózou jako hlavním znakem","synonyms":["Epstein-Barr virus susceptibility with hemophagocytic lymphohistiocytosis as a major feature"]},"uk":{"name":"Сприйнятливість до EBV з гемофагоцитарним лімфогістіоцитозом як основною ознакою","synonyms":["Сприйнятливість до вірусу Епштейна-Барр з гемофагоцитарним лімфогістіоцитозом як основною ознакою"]}},"xrefs":[{"source":"UMLS","code":"C5925063","qualifier":"E","icd_relation":null,"validated":true}],"associations":[],"incoming_associations":[],"preferential_parent":{"orpha":98004,"name":"Rare immune disease"},"parents":[{"orpha":664456,"name":"Immune dysregulation disease with immunodeficiency associated with EBV susceptibility","classifications":[156,195]}],"children":[{"orpha":238505,"name":"Combined immunodeficiency due to CD27 deficiency","type":"Disease"},{"orpha":2442,"name":"X-linked lymphoproliferative disease","type":"Clinical group"}],"genes":[],"genes_via_subtypes":[],"inheritance":[],"onset":[],"prevalence":[],"phenotypes":null}